American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.

[1]  A. Gulsvik,et al.  Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. , 2003, Respiratory medicine.

[2]  G. Raghu,et al.  Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) , 2009, European Respiratory Journal.

[3]  B. Madden,et al.  A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease. , 2006, Vascular pharmacology.

[4]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[5]  D. Schroeder,et al.  High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.

[6]  J. Allen,et al.  Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. , 1978, The American journal of medicine.

[7]  I. D. Johnston,et al.  British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival , 2006, Thorax.

[8]  A. Wells,et al.  Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[9]  N. Müller,et al.  Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. , 2006, AJR. American journal of roentgenology.

[10]  Y. Kondoh,et al.  Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease , 2009, European Respiratory Review.

[11]  K. Brown,et al.  Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. , 2009, Chest.

[12]  I. D. Johnston,et al.  Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. , 2000, American journal of respiratory and critical care medicine.

[13]  J. Stewart,et al.  A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[14]  Zhenwu Lin,et al.  Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis , 2003, Human Genetics.

[15]  R. Dowling,et al.  Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. , 1993, The Journal of thoracic and cardiovascular surgery.

[16]  G. Raghu,et al.  Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. , 2008, American journal of respiratory and critical care medicine.

[17]  D. Bouros,et al.  Epidemiology of interstitial lung diseases in Greece. , 2009, Respiratory medicine.

[18]  J. Myers,et al.  Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. , 2005, Chest.

[19]  J M Kay,et al.  A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. , 2000, The Annals of thoracic surgery.

[20]  A. Wells,et al.  Update in diffuse parenchymal lung disease 2007. , 2008, American journal of respiratory and critical care medicine.

[21]  M. Chung,et al.  Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. , 2008, Radiology.

[22]  P. O'Byrne,et al.  Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[23]  D. Schroeder,et al.  Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. , 2010, American journal of respiratory and critical care medicine.

[24]  D. Coultas,et al.  Is idiopathic pulmonary fibrosis an environmental disease? , 2006, Proceedings of the American Thoracic Society.

[25]  T. McDonnell,et al.  Effectiveness of pulmonary rehabilitation in restrictive lung disease. , 2006, Journal of cardiopulmonary rehabilitation.

[26]  Jae-Kwan Song,et al.  Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis. , 2009, Respiratory medicine.

[27]  G. Laurent,et al.  Adult familial cryptogenic fibrosing alveolitis in the United Kingdom , 2000, Thorax.

[28]  G. Grau,et al.  Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. , 1993, The American journal of pathology.

[29]  G. Snell,et al.  Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. , 2009, Transplantation proceedings.

[30]  G. Raghu,et al.  Interstitial Lung Diseases: Genetic Predisposition and Inherited Interstitial Lung Diseases , 1993 .

[31]  K. Ann McKibbon,et al.  Systematic Reviews and Librarians , 2006, Libr. Trends.

[32]  F. Martinez,et al.  Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy , 2004, Expert opinion on pharmacotherapy.

[33]  K. Kuwano,et al.  Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. , 1997, The European respiratory journal.

[34]  V. Poletti,et al.  HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[35]  K. Imanaka,et al.  A pilot study of aerosolized N‐acetylcysteine for idiopathic pulmonary fibrosis , 2005, Respirology.

[36]  D. Morrison,et al.  Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. , 1992, Chest.

[37]  M. Horton,et al.  Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis , 2008, Thorax.

[38]  R G Gupta,et al.  Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.

[39]  S. Nathan,et al.  Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. , 2008, Chest.

[40]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[41]  J. Moran,et al.  Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. , 2009, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[42]  L. Richeldi,et al.  Corticosteroids for idiopathic pulmonary fibrosis. , 2003, The Cochrane database of systematic reviews.

[43]  J. Norris,et al.  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.

[44]  S. Kudoh,et al.  A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis , 2008, Journal of Medical Genetics.

[45]  A. Nicholson,et al.  Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. , 1997, Thorax.

[46]  G. Raghu,et al.  Genetic predisposition of idiopathic pulmonary fibrosis , 1997, Current opinion in pulmonary medicine.

[47]  G. Raghu,et al.  The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis , 2005, European Respiratory Journal.

[48]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[49]  J. Golden,et al.  Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. , 2007, The Journal of thoracic and cardiovascular surgery.

[50]  P. Grenier,et al.  Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. , 1991, Radiology.

[51]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[52]  A. Papp,et al.  Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. , 2001, Human pathology.

[53]  S. Kudoh,et al.  Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan , 2005 .

[54]  R. Chapela,et al.  Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. , 1998, Chest.

[55]  G. Hunninghake Antioxidant therapy for idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.

[56]  R. Kaplan,et al.  Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. , 2005, Journal of cardiopulmonary rehabilitation.

[57]  M. Uder,et al.  Progression of Fibrosis in Usual Interstitial Pneumonia: Serial Evaluation of the Native Lung after Single Lung Transplantation , 2007, Respiration.

[58]  B. Afessa,et al.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. , 2002, American journal of respiratory and critical care medicine.

[59]  P. Pellikka,et al.  Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. , 2004, Chest.

[60]  F. Martinez,et al.  Radiological versus histological diagnosis in UIP and NSIP: survival implications , 2003, Thorax.

[61]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[62]  E. Cameron,et al.  Efficacy of video assisted thoracoscopic lung biopsy: an historical comparison with open lung biopsy. , 1994, Thorax.

[63]  F. Martinez,et al.  Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification , 2005, Thorax.

[64]  A. Nicholson,et al.  The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[65]  R. Hubbard,et al.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.

[66]  G. Tipoe,et al.  The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. , 2001, American journal of respiratory and critical care medicine.

[67]  S. Harari,et al.  Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. , 2009, Respiratory medicine.

[68]  A. Nicholson,et al.  Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[69]  M. Akira,et al.  CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. , 1997, AJR. American journal of roentgenology.

[70]  I. D. Johnston,et al.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.

[71]  W. Travis,et al.  Early interstitial lung disease in familial pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.

[72]  N. Müller,et al.  Acute Exacerbation (Acute Lung Injury of Unknown Cause) in UIP and Other Forms of Fibrotic Interstitial Pneumonias , 2007, The American journal of surgical pathology.

[73]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[74]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[75]  R. Bloigu,et al.  Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia , 2006, Thorax.

[76]  A. Sonnenberg,et al.  Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. , 1997, Gastroenterology.

[77]  Y. Kondoh,et al.  Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? , 2005, Respiratory medicine.

[78]  S. Quadrelli,et al.  Radiological versus Histopathological Diagnosis of Usual Interstitial Pneumonia in the Clinical Practice: Does It Have Any Survival Difference? , 2009, Respiration.

[79]  A. Nicholson,et al.  The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.

[80]  M Ando,et al.  Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. , 1999, Radiology.

[81]  K. Ohta,et al.  Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. , 1992, The American review of respiratory disease.

[82]  S. Ichinose,et al.  Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis--elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. , 2007, Pathology, research and practice.

[83]  M. Selman,et al.  Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis , 2005, Human Genetics.

[84]  M. Selman,et al.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis , 2008, Human Genetics.

[85]  D. Lynch,et al.  Computed Tomographic Features of Idiopathic Fibrosing Interstitial Pneumonia: Comparison With Pulmonary Fibrosis Related to Collagen Vascular Disease , 2009, Journal of computer assisted tomography.

[86]  R. D. du Bois,et al.  Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. , 2000, Arthritis and rheumatism.

[87]  A. Nicholson,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features , 2006, European Respiratory Journal.

[88]  M. Steele,et al.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. , 2003, The Journal of thoracic and cardiovascular surgery.

[89]  E. Abraham Erratum: Targeted β2-Agonist Therapy , 2005 .

[90]  S. Swensen,et al.  Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. , 1998, American journal of respiratory and critical care medicine.

[91]  A. Nicholson,et al.  Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. , 2003, American journal of clinical pathology.

[92]  T. Hartman,et al.  Diffuse bronchiolar disease due to chronic occult aspiration. , 2006, Mayo Clinic proceedings.

[93]  T. Laitinen,et al.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.

[94]  Y. Kondoh,et al.  Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia , 2005, European Respiratory Journal.

[95]  D. Schwartz,et al.  Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[96]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[97]  T. Johkoh,et al.  Prognostic factors in rapidly progressive interstitial pneumonia , 2010, Respirology.

[98]  R. Strawderman,et al.  Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. , 2001, The American journal of medicine.

[99]  Susan Murray,et al.  Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? , 2007, American journal of respiratory and critical care medicine.

[100]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[101]  R. Cavallazzi,et al.  Aspiration pneumonitis and aspiration pneumonia. , 2009, The New England journal of medicine.

[102]  S. Mallick Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. , 2008, Respiratory medicine.

[103]  M. Kamboh,et al.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.

[104]  A. Wells Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled , 2006, European Respiratory Journal.

[105]  N. Grishin,et al.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. , 2009, American journal of human genetics.

[106]  H. Collard,et al.  Sildenafil improves walk distance in idiopathic pulmonary fibrosis. , 2007, Chest.

[107]  Cotes Je,et al.  LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.

[108]  Naftali Kaminski,et al.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.

[109]  K. Brigham,et al.  Effects of aerosol vs IV UT-15 on prostaglandin H2 analog-induced pulmonary hypertension in sheep. , 2005, Chest.

[110]  Johny Verschakelen,et al.  High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.

[111]  L. Fasano,et al.  The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. , 2006, Respiratory care.

[112]  T. Suarez,et al.  Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. , 2009, Chest.

[113]  D. Jastrzębski,et al.  Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[114]  E. Taskinen,et al.  Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.

[115]  A. Nicholson,et al.  Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. , 2004, Chest.

[116]  J. Darbyshire,et al.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.

[117]  H. Collard,et al.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. , 2009, Chest.

[118]  L. Cecchini,et al.  Mechanical Ventilation in Patients with End-Stage Idiopathic Pulmonary Fibrosis , 2009, Respiration.

[119]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[120]  Naftali Kaminski,et al.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[121]  赤木 隆紀 Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis , 2010 .

[122]  I. D. Johnston,et al.  Idiopathic pulmonary fibrosis and hepatitis C virus infection. , 1993, The American review of respiratory disease.

[123]  T. Takishima,et al.  Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. , 1994, The Tohoku journal of experimental medicine.

[124]  N. Kohno,et al.  Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[125]  M. Yoshida,et al.  The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis. , 1997, The European respiratory journal.

[126]  R. Hubbard,et al.  Risk of cryptogenic fibrosing alveolitis in metal workers , 2000, The Lancet.

[127]  G. Butrous,et al.  Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis , 2010, Lung.

[128]  S. Sahn,et al.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.

[129]  D. Sugarbaker,et al.  Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. , 2006, The Journal of thoracic and cardiovascular surgery.

[130]  J. Ryu,et al.  Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. , 2004, Chest.

[131]  A. Nicholson,et al.  Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.

[132]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[133]  W. Seeger,et al.  Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. , 1999, American journal of respiratory and critical care medicine.

[134]  N L Müller,et al.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. , 1989, Radiology.

[135]  R. Strawderman,et al.  Histopathologic variability in usual and nonspecific interstitial pneumonias. , 2001, American journal of respiratory and critical care medicine.

[136]  G. Raghu,et al.  Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. , 2005, Chest.

[137]  M. Selman,et al.  AMERICAN THORACIC SOCIETY; EUROPEAN RESPIRATORY SOCIETY; AMERICAN COLLEGE OF CHEST PHYSICIANS. IDIOPATHIC PULMONARY FIBROSIS: PREVAILING AND EVOLVING HYPOTHESES ABOUT ITS PATHOGENESIS AND IMPLICATIONS FOR THERAPY , 2001 .

[138]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[139]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[140]  Jonathan Haines,et al.  Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. , 2002, American journal of respiratory and critical care medicine.

[141]  Y. Castier,et al.  Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis , 2009, Annals of Internal Medicine.

[142]  G. Raghu,et al.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.

[143]  G. Paone,et al.  Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens. , 2008, European review for medical and pharmacological sciences.

[144]  I. D. Johnston,et al.  Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. , 1998, American journal of respiratory and critical care medicine.

[145]  F. Martinez,et al.  Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.

[146]  榎本 達治 Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis , 2003 .

[147]  R. Crystal,et al.  Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.

[148]  R. Hubbard,et al.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK , 2006, Thorax.

[149]  A. Rubin,et al.  Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids. , 2006, Respiratory medicine.

[150]  T. King,et al.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.

[151]  Y. Kondoh,et al.  Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis , 2008, Respirology.

[152]  S. Nathan,et al.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. , 2006, Chest.

[153]  J. Egan,et al.  The 3’ untranslated region of tumor necrosis factor-a is highly conserved in idiopathic pulmonary fibrosis (IPF). , 2001 .

[154]  Y. Kondoh,et al.  A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis , 2010, European Respiratory Journal.

[155]  M. Santos,et al.  [Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit. A study of 20 cases]. , 2003, Medicina clinica.

[156]  M. Corretti,et al.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. , 2009, American journal of respiratory and critical care medicine.

[157]  R. Newton,et al.  A study of the cough reflex in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[158]  P. Spiegler,et al.  Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease. , 2006, Journal of cardiopulmonary rehabilitation.

[159]  N. Kaminski,et al.  Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern , 2007, PloS one.

[160]  L. Way,et al.  Idiopathic pulmonary fibrosis: How often is it really idiopathic? , 2005, Journal of Gastrointestinal Surgery.

[161]  A. Mehta,et al.  Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease. , 2008, Respiratory medicine.

[162]  J. Myers,et al.  Idiopathic pulmonary fibrosis in patients younger than 50 years. , 2005, Mayo Clinic proceedings.

[163]  P. Pellikka,et al.  The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. , 2005, Chest.

[164]  D. Lynch,et al.  Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[165]  F. D'Ovidio,et al.  Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[166]  R. D. du Bois,et al.  Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. , 2009, Chest.

[167]  D. Hansell,et al.  Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension , 2009, Thorax.

[168]  M. R. Harris The librarian's roles in the systematic review process: a case study. , 2005, Journal of the Medical Library Association : JMLA.

[169]  W. Seeger,et al.  Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial , 2002, The Lancet.

[170]  D. Fairclough,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2010 .

[171]  M. Wahidi,et al.  Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. , 2002, Chest.

[172]  P. Lansdorp,et al.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.

[173]  M. Raza Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis , 2009 .

[174]  M. Mishima,et al.  Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. , 2007, Chest.

[175]  L. Richeldi,et al.  Immunomodulatory agents for idiopathic pulmonary fibrosis. , 2003, The Cochrane database of systematic reviews.

[176]  坂本 晋 Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis , 2010 .

[177]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[178]  G. Raghu,et al.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. , 1999, Chest.

[179]  N. Kodallı,et al.  Acute exacerbation of interstitial fibrosis after pulmonary resection. , 2006, The Annals of thoracic surgery.

[180]  J. Stewart,et al.  Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis. , 2001, Respiratory medicine.

[181]  R. McIntyre,et al.  Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. , 1993, Chest.

[182]  J. McGowan,et al.  Systematic reviews need systematic searchers. , 2005, Journal of the Medical Library Association : JMLA.

[183]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[184]  P. Bardin,et al.  Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. , 1991, Thorax.

[185]  J. Kere,et al.  ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. , 2006, American journal of human genetics.

[186]  R. McFadden Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.

[187]  Susan Murray,et al.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? , 2004, American journal of respiratory and critical care medicine.

[188]  D. Lynch,et al.  Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. , 2008, Radiology.

[189]  M A Schork,et al.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.

[190]  E. Bagiella,et al.  Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[191]  G. Hunninghake,et al.  Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.

[192]  A. Kondoo Acute Exacerbation in Idiopathic Interstitial Pneumonia , 1989 .

[193]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .

[194]  D. Valeyre,et al.  Videothoracoscopic lung biopsy in diffuse infiltrative lung diseases: a 5-year surgical experience. , 1998, The Annals of thoracic surgery.

[195]  A. Limper,et al.  Idiopathic pulmonary fibrosis: is it a familial disease? , 2006, Current opinion in pulmonary medicine.

[196]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[197]  J E Aldrich,et al.  Chronic infiltrative lung disease: comparison of diagnostic accuracies of radiography and low- and conventional-dose thin-section CT. , 1994, Radiology.

[198]  K. Welsh,et al.  Analysis of Tumor Necrosis Factor- α , Lymphotoxin- α , Tumor Necrosis Factor Receptor II, and Interleukin-6 Polymorphisms in Patients with Idiopathic Pulmonary Fibrosis , 2001 .

[199]  G. Raghu,et al.  Telomere shortening in familial and sporadic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.

[200]  M. Yonemaru,et al.  Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. , 1997, The European respiratory journal.

[201]  D. Geddes,et al.  alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. , 1977, Lancet.

[202]  S. Swensen,et al.  Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. , 1997, Radiology.

[203]  S. Nagai,et al.  Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. , 2002, Internal medicine.

[204]  J. Egan,et al.  Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis , 2003, Genes and Immunity.

[205]  A. Katzenstein,et al.  Transbronchial biopsy in usual interstitial pneumonia. , 2006, Chest.

[206]  V. Ambrosini,et al.  Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF , 2004, Thorax.

[207]  R. Strawderman,et al.  Clinical significance of histological classification of idiopathic interstitial pneumonia , 2002, European Respiratory Journal.

[208]  G. Raghu,et al.  Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.

[209]  M. Kitaichi,et al.  Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[210]  D. Schroeder,et al.  Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. , 2000, American journal of respiratory and critical care medicine.

[211]  J. Behr,et al.  Brain natriuretic peptide is a prognostic parameter in chronic lung disease. , 2006, American journal of respiratory and critical care medicine.

[212]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[213]  Y. Castier,et al.  Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. , 2003, The Journal of thoracic and cardiovascular surgery.

[214]  K. Welsh,et al.  Analysis of IL-12 p40 subunit gene and IFN-γ G5644A polymorphisms in Idiopathic Pulmonary Fibrosis , 2003, Respiratory research.

[215]  F. Martinez,et al.  Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.

[216]  R. Trisolini,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: report of a series , 2003, European Respiratory Journal.

[217]  G. Darling,et al.  Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. , 2005, The Annals of thoracic surgery.

[218]  F. Graham,et al.  Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. , 1998, The American journal of pathology.

[219]  W. Gilks,et al.  Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[220]  C. Guérin,et al.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. , 2001, Chest.

[221]  S. Nathan,et al.  Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. , 2007, American journal of respiratory and critical care medicine.

[222]  M. Nishimura,et al.  Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis , 2006, Respirology.

[223]  G. Raghu,et al.  Usual Interstitial Pneumonia , 2001, Seminars in respiratory and critical care medicine.

[224]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[225]  E. Alton,et al.  Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A. , 1989, Respiratory medicine.

[226]  B. Carlin,et al.  PULMONARY REHABILITATION IN INTERSTITIAL LUNG DISEASE: BENEFITS AND PREDICTORS OF RESPONSE , 2009 .

[227]  G. Oster,et al.  Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[228]  K. Kishi,et al.  Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. , 2005, Internal medicine.

[229]  Douglas Curran-Everett,et al.  Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. , 2004, Chest.

[230]  I. Stříž,et al.  Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. , 2006, Tissue antigens.

[231]  H. Mal,et al.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. , 2001, Chest.

[232]  Gary K Grunwald,et al.  Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. , 2008, Radiology.

[233]  G. Raghu Idiopathic pulmonary fibrosis. A rational clinical approach. , 1987, Chest.

[234]  H. Collard,et al.  Acute exacerbations of idiopathic pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.

[235]  Jin Woo Song,et al.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[236]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[237]  F. Martinez,et al.  The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[238]  K. Chida,et al.  Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. , 2000, Thorax.

[239]  A. Holland,et al.  Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease , 2008, Thorax.

[240]  篠田 裕美 Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis , 2012 .

[241]  H. Collard,et al.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.

[242]  D. Schwartz,et al.  Determinants of progression in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[243]  K. Torén,et al.  Occupational exposure and severe pulmonary fibrosis. , 2007, Respiratory medicine.

[244]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[245]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[246]  C. Vogelmeier,et al.  Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. , 1997, American journal of respiratory and critical care medicine.

[247]  K. Tomii,et al.  Acute Exacerbation Of Interstitial Pneumonia Following Surgical Lung Biopsy , 2012, ATS 2012.

[248]  G. Raghu,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2009, European Respiratory Journal.

[249]  Yoshiyuki Suzuki,et al.  Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[250]  P. Enright,et al.  The six-minute walk test. , 2003, Respiratory care.

[251]  T. Honda,et al.  Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. , 1997, Thorax.

[252]  M. Mejía,et al.  Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. , 2004, Chest.

[253]  T. Hartman,et al.  Familial idiopathic pulmonary fibrosis: clinical features and outcome. , 2005, Chest.

[254]  M. Olschewski,et al.  Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[255]  A. Nicholson,et al.  Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. , 2003, American journal of respiratory and critical care medicine.

[256]  F. Martinez,et al.  The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis , 2005, Annals of Internal Medicine.

[257]  K. Chida,et al.  Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. , 2006, Chest.

[258]  David A Lynch,et al.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.

[259]  D. Geddes,et al.  α1-ANTITRYPSIN PHENOTYPES IN FIBROSING ALVEOLITIS AND RHEUMATOID ARTHRITIS , 1977, The Lancet.

[260]  A. Woodcock,et al.  The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. , 1999, American journal of respiratory and critical care medicine.

[261]  G. Raghu,et al.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[262]  M. Sutton,et al.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. , 2003, American journal of respiratory and critical care medicine.

[263]  Haiyang Li,et al.  BK and JC Polyomaviruses Are Not Associated with Idiopathic Pulmonary Fibrosis , 2005, Journal of Clinical Microbiology.

[264]  D. Visscher,et al.  Histologic spectrum of idiopathic interstitial pneumonias. , 2006, Proceedings of the American Thoracic Society.

[265]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.

[266]  N. Müller,et al.  Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function , 2005, Korean journal of radiology.

[267]  J. Myers,et al.  Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. , 2008, Chest.

[268]  R. G. Parrish,et al.  Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. , 1996, American journal of respiratory and critical care medicine.

[269]  R. Hubbard,et al.  Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study. , 1997, The European respiratory journal.

[270]  D. Mahler,et al.  Minimal important difference of the transition dyspnoea index in a multinational clinical trial , 2003, European Respiratory Journal.

[271]  M. Selman,et al.  Update in diffuse parenchymal lung disease 2012. , 2013, American journal of respiratory and critical care medicine.

[272]  I. Stříž,et al.  Correlation of IL‐1alpha and IL‐4 Gene Polymorphisms and Clinical Parameters in Idiopathic Pulmonary Fibrosis , 2007, Scandinavian journal of immunology.

[273]  R. Hubbard,et al.  The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.

[274]  Y. Kawabata,et al.  Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. , 1993, Chest.

[275]  G. Hunninghake,et al.  Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosis , 2002, European Respiratory Journal.

[276]  W. Thurlbeck,et al.  Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. , 2001, American journal of respiratory and critical care medicine.

[277]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[278]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[279]  K. Welsh,et al.  Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[280]  Ivana V. Yang,et al.  Gene expression profiling of familial and sporadic interstitial pneumonia. , 2007, American journal of respiratory and critical care medicine.

[281]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[282]  H. Collard,et al.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[283]  A. Nicholson,et al.  Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.

[284]  Stefano Nava,et al.  Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis , 1999, Thorax.

[285]  W. Travis,et al.  Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[286]  P. Zimmerman,et al.  Cytokine gene polymorphisms in idiopathic pulmonary fibrosis , 2004, Internal medicine journal.

[287]  M. Vassallo,et al.  Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis , 2005, Palliative medicine.

[288]  J. Oates,et al.  Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis , 2003, Journal of Clinical Microbiology.

[289]  J. McDougall,et al.  Colchicine in the treatment of pulmonary fibrosis. , 1993, Chest.

[290]  J. Wiggins,et al.  Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. , 1990, Respiratory medicine.

[291]  V. Cottin,et al.  Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. , 2005, American journal of respiratory and critical care medicine.

[292]  M. Reichlin,et al.  Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype. , 1984, The American journal of medicine.

[293]  M. Raza BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis , 2009 .

[294]  R. Trisolini,et al.  NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[295]  Y. Açil,et al.  Antiinflammatory and Antifibrotic Properties of Colchicine: Implications for Idiopathic Pulmonary Fibrosis , 1997, Lung.

[296]  P. Jolliet,et al.  Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis , 2001, Intensive Care Medicine.

[297]  P. Brillet,et al.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.

[298]  M. Molina-Molina,et al.  Características clínicas y pronóstico de los pacientes con fibrosis pulmonar que ingresan en cuidados intensivos por insuficiencia respiratoria. Análisis de 20 casos , 2003 .

[299]  T. Hartman,et al.  Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. , 2008, Respiratory medicine.

[300]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[301]  D. Curran‐Everett,et al.  The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. , 2004, The American journal of medicine.

[302]  C. Ruppert,et al.  Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias , 2006, European Respiratory Journal.

[303]  S. Abe,et al.  Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. , 2000, American journal of respiratory and critical care medicine.

[304]  N. Müller,et al.  Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. , 2008, American journal of respiratory and critical care medicine.

[305]  I. D. Johnston,et al.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.

[306]  C A Smith,et al.  Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. , 1993, Journal of immunology.

[307]  Katsutoshi Nakayama,et al.  Anticoagulant therapy for idiopathic pulmonary fibrosis. , 2005, Chest.

[308]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[309]  M. Yamaguchi,et al.  Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. , 1994, American journal of respiratory and critical care medicine.

[310]  M. Vogeser,et al.  Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.

[311]  A. Woodcock,et al.  Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.

[312]  H. Itoh,et al.  Usual interstitial pneumonia: histologic correlation with high-resolution CT. , 1992, Radiology.

[313]  G. Raghu,et al.  Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. , 2009, Chest.

[314]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[315]  A. Nicholson,et al.  Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. , 2003, The Journal of thoracic and cardiovascular surgery.

[316]  L. Fasano,et al.  Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. , 1996, Thorax.

[317]  K. Brown,et al.  Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. , 2008, Chest.

[318]  H. Collard,et al.  Classification and Natural History of the Idiopathic Interstitial Pneumonias Who Is at Risk of Ipf? What Causes Ipf? , 2022 .

[319]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[320]  R. Hubbard,et al.  Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. , 2009, Respiratory medicine.

[321]  N. Kohno,et al.  New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. , 1989, Chest.

[322]  D. V. van Thiel,et al.  Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C , 2002, Journal of medical virology.

[323]  K. Welsh,et al.  Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[324]  F. Al-Hameed,et al.  Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. , 2004, Canadian respiratory journal.